Literature DB >> 17089000

Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures.

Yuelin Zhu1, Antai Wang, Minetta C Liu, Alan Zwart, Richard Y Lee, Ann Gallagher, Yue Wang, William R Miller, J Michael Dixon, Robert Clarke.   

Abstract

Established human breast cancer cell lines are widely used as experimental models in breast cancer research. While these cell lines and their variants share many phenotypic characteristics with human breast tumors, the extent to which they reflect the underlying molecular biology of breast cancer remains controversial. We explored this issue using a probabilistic rather than heuristic approach. Data from gene expression microarrays were used to compare the global structures of the transcriptomes of three estrogen receptor alpha positive (ER+) human breast cancer cell lines (MCF-7, T47D, ZR-75-1) and 13 human breast tumors (11 ER+; 2 ER-). Linear representations of the respective data structures were obtained by deriving those top principal components (PCs) required to capture > or =80% of the cumulative variance for each data set (M PCs). We then identified those genes most highly correlated with the M PCs (Pearson's correlation coefficient r > or =0.800) and identified a group of 36 genes commonly correlated with both the cell line (M = 5 PCs) and tumor (M = 6 PCs) data structures. All 36 common genes were correlated with PC1 from the breast tumor data: 21/36 genes were correlated with PC1, 14/36 genes correlated with PC2, and 1/36 genes correlated with PC3 from the cell line data. Genes important in defining the data structures include NFkappaB p65, IGFBP-6, ornithine decarboxylase-1, and paxillin. When data from MDA-MB-435 xenografts (ER-) were included in the analysis, we were unable to find any common genes between these xenografts and the breast tumors. These data clearly imply that MCF-7, T47D, and ZR-75-1 cells and ER+ breast tumors share substantial global similarities in the structures of their respective transcriptomes, and that these cell lines are good models in which to identify molecular events that are likely to be important in some ER+ human breast cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17089000

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  22 in total

Review 1.  The properties of high-dimensional data spaces: implications for exploring gene and protein expression data.

Authors:  Robert Clarke; Habtom W Ressom; Antai Wang; Jianhua Xuan; Minetta C Liu; Edmund A Gehan; Yue Wang
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

2.  Rapid and ultrasensitive detection of endocrine disrupting chemicals using a nanosensor-enabled cell-based platform.

Authors:  Ngoc D B Le; Xian Wang; Yingying Geng; Rui Tang; Gulen Yesilbag Tonga; Ziwen Jiang; Vincent M Rotello
Journal:  Chem Commun (Camb)       Date:  2017-07-24       Impact factor: 6.222

3.  Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs.

Authors:  Luigi Cicatiello; Margherita Mutarelli; Oli M V Grober; Ornella Paris; Lorenzo Ferraro; Maria Ravo; Roberta Tarallo; Shujun Luo; Gary P Schroth; Martin Seifert; Christian Zinser; Maria Luisa Chiusano; Alessandra Traini; Michele De Bortoli; Alessandro Weisz
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

4.  Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells.

Authors:  Eleanor F Need; Luke A Selth; Tiffany J Harris; Stephen N Birrell; Wayne D Tilley; Grant Buchanan
Journal:  Mol Endocrinol       Date:  2012-09-28

5.  Identification of novel transcript variants of estrogen receptor α, β and progesterone receptor gene in human endometrium.

Authors:  Anette Springwald; Claus Lattrich; Maciek Skrzypczak; Regina Goerse; Olaf Ortmann; Oliver Treeck
Journal:  Endocrine       Date:  2010-03-25       Impact factor: 3.633

6.  Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1.

Authors:  Iván P Uray; Qiang Shen; Hye-Sook Seo; HeeTae Kim; William W Lamph; Reid P Bissonnette; Powel H Brown
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

7.  Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition.

Authors:  H Karimi Kinyamu; Jennifer B Collins; Sherry F Grissom; Pratibha B Hebbar; Trevor K Archer
Journal:  Mol Carcinog       Date:  2008-11       Impact factor: 4.784

8.  Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Authors:  Robert Clarke; Ayesha N Shajahan; Rebecca B Riggins; Younsook Cho; Anatasha Crawford; Jianhua Xuan; Yue Wang; Alan Zwart; Ruchi Nehra; Minetta C Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03       Impact factor: 4.292

9.  Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells.

Authors:  Vanity McMurtry; Ann-Marie Simeone; René Nieves-Alicea; Ana M Tari
Journal:  Clin Exp Metastasis       Date:  2008-12-27       Impact factor: 5.150

10.  Protein tyrosine phosphatase 4A2 expression predicts overall and disease-free survival of human breast cancer and is associated with estrogen and progestin receptor status.

Authors:  Sarah A Andres; James L Wittliff; Alan Cheng
Journal:  Horm Cancer       Date:  2013-04-09       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.